Literature DB >> 12434406

P-glycoprotein-mediated transport of berberine across Caco-2 cell monolayers.

Han-Joo Maeng1, Ho-Jung Yoo, In-Wha Kim, Im-Sook Song, Suk-Jae Chung, Chang-Koo Shim.   

Abstract

The objective of this study was to investigate the mechanisms by which berberine is transported in the secretory and absorptive directions across Caco-2 cell monolayers. The basolateral-to-apical (B-A) flux was 30-fold greater than the apical-to-basolateral flux and temperature dependent (i.e., drastic decrease at 4 degrees C compared with 37 degrees C). The above results suggest the involvement of a carrier-mediated active transport mechanism for the B-A transport of berberine. However, no significant concentration dependency for the permeability (P(app)) of berberine was observed for B-A transport over a concentration range of 5-300 microM, indicating that the K(m) value of berberine for the carrier system is greater than 300 microM. Well-documented P-glycoprotein (P-gp) substrates such as verapamil, daunomycin, and rhodamine123 inhibited the B-A flux of berberine, whereas tetraethylammonium and taurocholate did not, suggesting that P-gp is involved in the transport. For the case of daunomycin, the B-A flux, but not the apical-to-basolateral flux, was significantly increased after pretreatment of the cell monolayers with berberine. In addition, the uptake of 1 microM daunomycin into Caco-2 cells was decreased as a result of this pretreatment. These results suggest that the repeated administration of berberine may up-regulate P-gp functions in Caco-2 cells. If this occurs in the gastrointestinal epithelial cells, the repeated administration of berberine may reduce the gastrointestinal absorption of P-gp substrates including chemotherapeutic agents such as daunomycin. Copyright 2002 Wiley-Liss, Inc. and the American Pharmaceutical Association J Pharm Sci 91:2614-2621, 2002

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12434406     DOI: 10.1002/jps.10268

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  27 in total

1.  Assessment and modulation of phillyrin absorption by P-gp using Caco-2 cells and MDR1-MDCKII cells.

Authors:  Yun-Xia Li; Liang-Hong Ye; Xue-Hua Jiang; Cheng Peng
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2011-02-20       Impact factor: 2.441

2.  Effects of berberine on the blood concentration of cyclosporin A in renal transplanted recipients: clinical and pharmacokinetic study.

Authors:  Xiaochun Wu; Qing Li; Huawen Xin; Airong Yu; Mingyuan Zhong
Journal:  Eur J Clin Pharmacol       Date:  2005-08-26       Impact factor: 2.953

3.  Enhancement of sodium caprate on intestine absorption and antidiabetic action of berberine.

Authors:  Xiao-Yan Lv; Jing Li; Ming Zhang; Chun-Mei Wang; Zheng Fan; Chun-Yan Wang; Li Chen
Journal:  AAPS PharmSciTech       Date:  2010-03-17       Impact factor: 3.246

Review 4.  Cancer prevention and therapy through the modulation of the tumor microenvironment.

Authors:  Stephanie C Casey; Amedeo Amedei; Katia Aquilano; Asfar S Azmi; Fabian Benencia; Dipita Bhakta; Alan E Bilsland; Chandra S Boosani; Sophie Chen; Maria Rosa Ciriolo; Sarah Crawford; Hiromasa Fujii; Alexandros G Georgakilas; Gunjan Guha; Dorota Halicka; William G Helferich; Petr Heneberg; Kanya Honoki; W Nicol Keith; Sid P Kerkar; Sulma I Mohammed; Elena Niccolai; Somaira Nowsheen; H P Vasantha Rupasinghe; Abbas Samadi; Neetu Singh; Wamidh H Talib; Vasundara Venkateswaran; Richard L Whelan; Xujuan Yang; Dean W Felsher
Journal:  Semin Cancer Biol       Date:  2015-04-10       Impact factor: 15.707

5.  Effect of goldenseal (Hydrastis canadensis) and kava kava (Piper methysticum) supplementation on digoxin pharmacokinetics in humans.

Authors:  Bill J Gurley; Ashley Swain; Gary W Barone; D Keith Williams; Philip Breen; C Ryan Yates; Leslie B Stuart; Martha A Hubbard; Yudong Tong; Sreekhar Cheboyina
Journal:  Drug Metab Dispos       Date:  2006-11-01       Impact factor: 3.922

6.  Vectorial transport of the plant alkaloid berberine by double-transfected cells expressing the human organic cation transporter 1 (OCT1, SLC22A1) and the efflux pump MDR1 P-glycoprotein (ABCB1).

Authors:  Anne T Nies; Elke Herrmann; Manuela Brom; Dietrich Keppler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-12-19       Impact factor: 3.000

7.  Effect of the flavonoids biochanin A and silymarin on the P-glycoprotein-mediated transport of digoxin and vinblastine in human intestinal Caco-2 cells.

Authors:  Shuzhong Zhang; Marilyn E Morris
Journal:  Pharm Res       Date:  2003-08       Impact factor: 4.200

8.  Sodium caprate augments the hypoglycemic effect of berberine via AMPK in inhibiting hepatic gluconeogenesis.

Authors:  Ming Zhang; Xiaoyan Lv; Jing Li; Zhaojie Meng; Qiujing Wang; WenGuang Chang; Wei Li; Li Chen; Yanjun Liu
Journal:  Mol Cell Endocrinol       Date:  2012-08-16       Impact factor: 4.102

9.  Involvement of P-glycoprotein and multidrug resistance associated protein 1 on the transepithelial transport of a mercaptoacetamide-based histone-deacetylase inhibitor in Caco-2 cells.

Authors:  Zacharoula Konsoula; Mira Jung
Journal:  Biol Pharm Bull       Date:  2009-01       Impact factor: 2.233

10.  Possible role of P-glycoprotein in the neuroprotective mechanism of berberine in intracerebroventricular streptozotocin-induced cognitive dysfunction.

Authors:  Anil Kumar; Jitendriya Mishra; Kanwaljit Chopra; Dinesh K Dhull
Journal:  Psychopharmacology (Berl)       Date:  2015-10-08       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.